LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 201 filers reported holding LEGEND BIOTECH CORP in Q3 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $665,789 | -43.2% | 9,912 | -41.6% | 1.40% | -23.1% |
| Q2 2023 | $1,172,267 | +35.7% | 16,982 | -5.2% | 1.82% | +43.9% |
| Q1 2023 | $863,620 | -13.5% | 17,910 | -10.5% | 1.26% | -0.9% |
| Q4 2022 | $998,849 | -13.1% | 20,009 | -28.9% | 1.27% | +12.8% |
| Q3 2022 | $1,149,000 | -25.8% | 28,150 | -0.1% | 1.13% | -20.7% |
| Q2 2022 | $1,549,000 | -16.3% | 28,172 | -44.7% | 1.42% | +41.7% |
| Q1 2022 | $1,851,000 | -36.8% | 50,928 | -19.0% | 1.00% | -1.2% |
| Q4 2021 | $2,929,000 | +73.0% | 62,849 | +87.6% | 1.02% | +79.7% |
| Q3 2021 | $1,693,000 | – | 33,493 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 526,072 | $21,595,000 | 11.36% |
| Consonance Capital Management LP | 1,647,497 | $67,630,000 | 8.14% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,629,173 | $66,878,000 | 6.84% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,342,442 | $55,107,000 | 2.29% |
| Vivo Capital, LLC | 956,702 | $39,273,000 | 1.70% |
| Hudson Bay Capital Management LP | 1,878,374 | $77,107,000 | 0.93% |
| Capital International Sarl | 220,470 | $9,050,000 | 0.78% |
| Capital International, Inc./CA/ | 1,951,845 | $80,123,000 | 0.72% |
| Avidity Partners Management LP | 625,000 | $25,656,000 | 0.69% |
| INDUS CAPITAL PARTNERS, LLC | 94,678 | $3,887,000 | 0.66% |